Page 7 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Obesity Drug Set to Exceed Ozempic With $27B Sales by 2029

Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of $27 billion by 2029.

United kingdomAstrazeneca forxigaKevin marcaidaEli lilly mounjaroEli lillyNovo nordisk wegovyNovo nordisk ozempicRegulatory agencyNovo nordiskSuperiority over ozempicWeight lossPharma analystUnited kingdom medicinesWeight loss drugsWeight lossObesity medications

Obesity Drug Mounjaro To Surpass Ozempic With $27 Bn Sales In 2029: Report

Obesity Drug Mounjaro To Surpass Ozempic With $27 Bn Sales In 2029: Report
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomAstrazeneca forxigaNovo nordisk ozempicEli lilly mounjaroEli lillyNovo nordisk wegovyKevin marcaidaNovo nordiskRegulatory agencyPharma analystUnited kingdom medicines

Obesity drug Mounjaro to surpass Ozempic with $27 bn sales in 2029: Report

Eli Lilly's Mounjaro is poised to surpass Novo Nordisk's Ozempic (semaglutide) and become the leading drug by sales in the obesity and diabetes market, according to a report on Monday.Ozempic took the weight loss sector by storm in 2023, .

New yorkUnited statesUnited kingdomEli lilly mounjaroKevin marcaidaNovo nordisk ozempicEli lillyRegulatory agencyNovo nordiskPharma analystUnited kingdom medicines

Drug Makers Struggle to Replace Stimulants with Non-Addictive Alternatives

Drug Makers Struggle to Replace Stimulants with Non-Addictive Alternatives
hightimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hightimes.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCarl hartLorraine palmerRichard francisAxsome therapeutics incOtsuka pharmaceutical co ltdTeva pharmaceuticalsNeurocentria incl threonate magnesium saltColumbia universityExpress pharmaNeurocentria incL threonate magnesiumPharma analystClinical psychiatry

Novartis blockbuster drug Tasigna faces sales decline as US patent expiry looms: GlobalData

Novartis blockbuster drug Tasigna faces sales decline as US patent expiry looms: GlobalData
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

World health organizationAl qahirahKevin marcaidaModel listEssential medicinesPharma analystXspray pharmaMedicines patent pool